Patent · US Active

Anti-VEGF protein compositions and methods for producing the same

US11407813B2 · kind B2 · utility

2Cited by

70References

20Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Andrew Tustian · Millwood, US
Ankit Vartak · Elmsford, US
Thomas Daly · New City, US
Erica Pyles · New City, US
Nisha Palackal · White Plains, US
Shunhai Wang · Scarsdale, US
Ning Li · New Canaan, US
Matthew C. Franklin · Great Neck, US

Key dates

Filing date	Oct 1, 2021
Grant date	Aug 9, 2022
Priority date	—
Expiry date	Oct 1, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG01N2030/027
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure pertains compositions comprising anti-VEGF proteins and methods for producing such compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.